Sage Therapeutics' rare disease drug meets main goal in mid-stage study-February 2024-www.financetom.com

Sage Therapeutics' rare disease drug meets main goal in mid-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Sage Therapeutics' rare disease drug meets main goal in mid-stage study

Jun 11, 2024 4:12 AM

June 11 (Reuters) - Sage Therapeutics ( SAGE ) said on

Tuesday its experimental drug met the main goal of a mid-stage

study in patients with a type of rare disease known as

Huntington's disease.

Previous page： Jazz Pharmaceuticals Insider Sold Shares Worth $456,617, According to a Recent SEC Filing Next page： C. H. Robinson Worldwide Insider Sold Shares Worth $1,143,493, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Jazz Pharmaceuticals Insider Sold Shares Worth $456,617, According to a Recent SEC Filing

Nov 13, 2024

05:46 PM EST, 11/13/2024 (MT Newswires) -- Neena M Patil, EVP & Chief Legal Officer, on November 08, 2024, sold 3,700 shares in Jazz Pharmaceuticals ( JAZZ ) for $456,617. Following the Form 4 filing with the SEC, Patil has control over a total of 33,048 shares of the company, with 33,048 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1232524/000176558124000088/xslF345X05/edgardoc.xml ...

C. H. Robinson Worldwide Insider Sold Shares Worth $1,143,493, According to a Recent SEC Filing

Nov 13, 2024

05:45 PM EST, 11/13/2024 (MT Newswires) -- Michael John Short, President, Global Forwarding, on November 11, 2024, sold 10,408 shares in C. H. Robinson Worldwide (CHRW) for $1,143,493. Following the Form 4 filing with the SEC, Short has control over a total of 70,943 shares of the company, with 70,943 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1043277/000143774924034969/xslF345X05/rdgdoc.xml ...

Oddity Tech to Repurchase $100 Million of Shares From L Catterton Managed Fund

Nov 13, 2024

05:45 PM EST, 11/13/2024 (MT Newswires) -- Oddity Tech ( ODD ) entered a deal with a fund managed by L Catterton to repurchase about 2.35 million of its Class A ordinary shares at $42.501 apiece for roughly $100 million, Oddity said late Wednesday. The company said it plans to fund the deal from its cash resources. The transaction is...

Nu Q3 Earnings, Revenue Rise; Shares Fall After-Hours

Nov 13, 2024

05:45 PM EST, 11/13/2024 (MT Newswires) -- Nu Holdings ( NU ) reported Q3 earnings late Wednesday of $0.1132 per diluted share, up from $0.0624 a year earlier. Analysts polled by Capital IQ expected $0.10. Revenue for the quarter ended Sept. 30 rose to $2.94 billion from $2.14 billion a year earlier. Analysts surveyed by Capital IQ expected $2.95 billion....